A comparison of 99Tcm-MDP and 99Tcm-MIBI in the detection of breast cancer
暂无分享,去创建一个
[1] Shuu-Jiun Wang,et al. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses , 1994, European Journal of Nuclear Medicine.
[2] R. Taillefer. The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. , 1999, Seminars in nuclear medicine.
[3] S. Lastoria,et al. Scintimammography (Smm) with 99mTc-Mdp: An Overview of the Experience at the National Cancer Institute of Napoli , 1997, Tumori.
[4] A. Robidoux,et al. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] M. Salvatore,et al. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Q. Sun,et al. 99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging. , 1995, Nuclear medicine communications.
[7] A. Chiti,et al. Case Report: Technetium-99M-Hexakis-2-Methoxy-Isobutyl-Isonitrile Imaging of Breast Cancer and Myocardial Infarction in the Same Patient , 1994, Tumori.
[8] Z. Burak,et al. Evaluation of palpable breast masses with 99Tcm‐MIBI: a comparative study with mammography and ultrasonography , 1994, Nuclear medicine communications.
[9] I. Mena,et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. , 1994, Journal of the American College of Surgeons.
[10] B. Lentle,et al. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] S. Minoshima,et al. [Visualization of the female breast in bone scintigraphy]. , 1992, Kaku igaku. The Japanese journal of nuclear medicine.
[12] J. Kronauge,et al. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] I. Gordon,et al. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] M. Brown,et al. The role of radionuclides in the patient with osteogenic sarcoma. , 1989, Seminars in roentgenology.
[15] Lee-Tzuu Chang,et al. A Method for Attenuation Correction in Radionuclide Computed Tomography , 1978, IEEE Transactions on Nuclear Science.
[16] J. Wolfe. Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.
[17] I. Mcdougall,et al. Concentration of 99mTc diphosphonate in breast tissue. , 1974, Radiology.
[18] R. A. Holmes,et al. A proposed mechanism for 99mTc-labeled polyphosphate and diphosphonate uptake by human breast tissue. , 1974, Radiology.
[19] L. Kalisher,et al. 99mTc-diphosphonate concentration in primary breast carcinoma. , 1973, Radiology.